Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. Neurosurgeon Toral Patel, M.D., and Neuro-Oncologist Michael Youssef, M.D., discuss how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.
Toral Patel, M.D. /
Michael Youssef, M.D.
July 12, 2024
